Regenerx Biopharms Inc

(RGRX)

By |

Profile

Regenerx Biopharmaceuticals Inc is a biopharmaceutical developer. It is focused on the development of a therapeutic peptide, Thymosin beta 4 (Tb4), for tissue and organ protection, repair and regeneration. The company has formulated Tb4 into three product candidates in clinical development: RGN-259, RGN-352, and RGN-137. Tb4 is a synthetic copy of a naturally occurring 43-amino acid peptide that is originally isolated from bovine thymus glands. RGN-259 is its preservative-free eye drop formulation of Tb4. RGN-352 is an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications that may be treated by systemic administration.

Contact Information

Website: www.regenerx.com
Email: info@regenerx.com
Main Phone: +1 301 208-9191
Address: 15245 Shady Grove Road
Address 2: Suite 470
State: MD
City / Town: Rockville
Country: USA
Postal Code: 20850

Issuer Information

Exchange: OTCQB
CEO: J. J. Finkelstein
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.10 $ -0.00705 (-6.59%)
Last Price 0.10 Change $ -0.00705 Change % -6.59 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.10 High 0.11 Low 0.0975 Prev Close 0.11
Last Trade Volume 72,275 52 Wk Hi 0.31 52 Wk Low 0.091
Market Cap 12.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 128,432,478.00 EPS (TTM) 0.00 PE Ratio N/A Exchange OTCQB
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
C. Lyons 1,000
C. Lyons 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.5 1.5 1.5 1.5
Low Target Price Estimate 1.5 1.5 1.5 1.5
Mean Target Price Estimate 1.5 1.5 1.5 1.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 11/01/17 11/01/17 11/01/17 11/01/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1